当前位置: 首页 > 医疗版 > 疾病专题 > 消化内科 > 胃疾病 > 胃癌
编号:13266227
胃癌患者化疗的医护一体化干预方法与干预效果评估(4)
http://www.100md.com 2018年11月25日 《中国医学创新》 2018年第33期
     [16] Elingarami S,Liu M,Fan J,et al.Applications of nanotechnology in gastric cancer:detection and prevention by nutrition[J].Journal of Nanoscience and Nanotechnology,2014,14(1):932-945.

    [17] Lee S J,Lee W W,Yoon H J,et al.Regional PET/CT after water gastric inflation for evaluating loco-regional disease of gastric cancer[J].European Journal of Radiology,2013,82(6):935-942.

    [18] Monim-UI-Mehboob M,Altaf M,Fettouhi M,et al.Synthesis,spectroscopic characterization and anti-cancer properties of new gold(Ⅲ)-alkanediamine complexes against gastric,prostate and ovarian cancer cells;crystal structure of [Au2(pn)2(Cl) 2]Cl2·H2O[J].Polyhedron,2013,61:225-234.

    [19] Zhang J,Hu H,Liang S,et al.Targeted radiotherapy with tumor vascular homing trimeric GEBP11 peptide evaluated by multimodality imaging for gastric cancer[J].Journal of Controlled Release,2013,172(1):322-329.

    [20] Hu W Q,Fang M,Zhao H L,et al.Tumor invasion unit in gastric cancer revealed by QDs-based in situ molecular imaging and multispectral analysis[J].Biomaterials,2014,35(13):4125-4132.

    (收稿日期:2018-09-10) (本文編辑:李莹莹), http://www.100md.com(阮淑芳 袁兰 熊秋萍)
上一页1 2 3 4


    参见:首页 > 医疗版 > 疾病专题 > 消化内科 > 胃疾病 > 胃癌